05/13/2024
6:15 AM | Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
6:09 AM | Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
6:45 AM | PFIZER INC (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
| Form SC 13G/A | |
02/14/2024
8:08 PM | Hydra LLC (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
| Form SC 13G/A | |
02/14/2024
7:51 PM | Blue Owl Capital Holdings LP (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
| Form SC 13G | |
02/14/2024
3:57 PM | CITADEL ADVISORS LLC (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
| Form SC 13G/A | |
02/09/2024
4:24 PM | Blackstone Holdings II L.P. (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
| Form SC 13G/A | |
|
02/07/2024
1:11 PM | BML Investment Partners, L.P. (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
| Form SC 13G/A | |
01/31/2024
3:26 PM | MCDADE MARK (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
8:20 PM | Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 424B5 | |
01/08/2024
8:19 AM | Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/14/2023
7:27 AM | Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/30/2023
7:25 AM | Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2023
5:14 PM | Thiara Parvinder (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
5:15 PM | Kulkarni Sandeep Chidambar (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2023
3:30 PM | Hydra LLC (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
| Form SC 13G | |
10/30/2023
4:16 PM | Longitude Capital Partners III, LLC (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
| Form SC 13D/A | |
10/30/2023
3:15 PM | Qiming U.S. Healthcare GP II, LLC (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
| Form SC 13D/A | |
10/27/2023
4:43 PM | Castelein Caley (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/27/2023
4:17 PM | Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/26/2023
4:00 PM | KANTOFF AARON (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/26/2023
4:34 PM | Kulkarni Sandeep Chidambar (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/26/2023
3:46 PM | Thiara Parvinder (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
7:25 PM | Kulkarni Sandeep Chidambar (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
7:26 PM | MCDADE MARK (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
7:29 PM | MIDDLEKAUFF W BRADFORD (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
7:30 PM | Robinson Ryan F. (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
7:31 PM | Srivastava Sapna (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
7:33 PM | Thiara Parvinder (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
7:18 PM | Castelein Caley (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
7:20 PM | CHYUNG YUNG H. (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
7:21 PM | Johnson Kevin Bruce (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
7:23 PM | Jones Susan Dana (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
7:24 PM | KANTOFF AARON (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
5:27 PM | Castelein Caley (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2023
5:27 PM | Chester Cariad (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2023
5:28 PM | CHYUNG YUNG H. (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2023
5:29 PM | Johnson Kevin Bruce (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2023
5:30 PM | Jones Susan Dana (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2023
5:31 PM | KANTOFF AARON (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2023
5:31 PM | Kulkarni Sandeep Chidambar (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Wall Street legend who predicted 2021 tech crash issues new warning (Ad) People around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions.
And he just issued an urgent WARNING for some of the most popular stocks in U.S. history. Watch his stock warning right here, 100% free of charge |
10/23/2023
5:32 PM | MIDDLEKAUFF W BRADFORD (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2023
5:33 PM | Robinson Ryan F. (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2023
5:34 PM | Thiara Parvinder (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/20/2023
8:23 PM | Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/19/2023
8:11 PM | Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2023
3:32 PM | Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
| Form 425 | |
10/10/2023
3:30 PM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K/A | |
10/06/2023
4:26 PM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
4:27 PM | Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
| Form 425 | |
10/06/2023
4:30 PM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2023
7:21 AM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2023
7:24 AM | Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
| Form 425 | |
09/15/2023
5:31 AM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 424B3 | |
09/14/2023
11:15 PM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form EFFECT | |
09/13/2023
3:28 PM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form S-4/A | |
09/13/2023
8:13 AM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2023
8:14 AM | Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
| Form 425 | |
09/11/2023
3:47 PM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form S-4/A | |
08/28/2023
6:38 AM | Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
| Form 425 | |
08/25/2023
3:34 PM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form S-4/A | |
08/14/2023
6:53 AM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/19/2023
6:57 PM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
07/06/2023
4:19 PM | Requadt Scott (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
4:20 PM | Fenton Mary Kay (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
3:32 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
| Form SC 13G | |
07/05/2023
4:10 PM | Requadt Scott (Reporting)
Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/05/2023
3:52 PM | Fenton Mary Kay (Reporting)
Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/22/2023
8:10 AM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/22/2023
8:12 AM | Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
| Form 425 | |
06/14/2023
5:56 PM | Agarwala Sandip (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
5:58 PM | Ildstad Suzanne (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
5:59 PM | MACKAY GEOFFREY (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
5:59 PM | MCDADE MARK (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
6:00 PM | Nader Francois (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
6:01 PM | Shah Gaurav (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
6:02 PM | Smith Karen L. (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
6:03 PM | Srivastava Sapna (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:41 PM | Ildstad Suzanne (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
5:24 PM | Ildstad Suzanne (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
3:21 PM | Ildstad Suzanne (Reporting)
Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
